1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. US Compounding Pharmacies Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. US Compounding Pharmacies Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. US Compounding Pharmacies Market Country Analysis
6.2 US Compounding Pharmacies Market Revenue 2017-2027 (US$ Million)
6.3 US Compounding Pharmacies Market Forecast Analysis
7. US Compounding Pharmacies Market Analysis – by Product
7.1 Oral Medications
- 7.1.1 Overview
- 7.1.2 Oral Medications: US Compounding Pharmacies Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Topical Medications
- 7.2.1 Overview
- 7.2.2 Topical Medications: US Compounding Pharmacies Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Suppositories
- 7.3.1 Overview
- 7.3.2 Suppositories: US Compounding Pharmacies Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. US Compounding Pharmacies Market Analysis – by Therapeutic Area
8.1 Pain Medications
- 8.1.1 Overview
- 8.1.2 Pain Medications: US Compounding Pharmacies Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Hormone Replacement Therapies
- 8.2.1 Overview
- 8.2.2 Hormone Replacement Therapies: US Compounding Pharmacies Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Dermatological Applications
- 8.3.1 Overview
- 8.3.2 Dermatological Applications: US Compounding Pharmacies Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. US Compounding Pharmacies Market – United States Analysis
9.1 United States
- 9.1.1 United States: US Compounding Pharmacies Market – Revenue
and Forecast to 2027 (US$ Million)
- 9.1.1.1 United States:
US Compounding Pharmacies Market Breakdown, by Product
- 9.1.1.2 United States:
US Compounding Pharmacies Market Breakdown, by Therapeutic Area
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Fagron
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Triangle compounding pharmacy
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Institutional pharmacy solutions, llc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 B. Braun melsungen ag
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Pharmedium services llc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Fresenius kabi ag
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Avella specialty pharmacy
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Pencol Compounding Pharmacy
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Vertisis custom pharmacy
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 US Compounding Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For US Compounding Pharmacies Market
